Vivos (RDGL) Shares Outstanding (Weighted Average) (2010 - 2025)

Vivos' (RDGL) quarterly Shares Outstanding (Weighted Average) came in at $452.7 million in Q4 2025, up 10.51% year-on-year from $409.7 million in Q4 2024, and little changed quarter-over-quarter from $452.0 million in Q3 2025.

Vivos (RDGL) Shares Outstanding (Weighted Average) (2010 - 2025) Analysis & Trends

Vivos has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $452.7 million for Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $452.7 million, up 10.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $452.7 million (up 10.51% YoY), and the FY2025 annual result was $452.7 million, up 10.51% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $452.7 million for Q4 2025 at Vivos, roughly flat from $452.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $453.5 million in Q2 2025 to a low of $1.3 million in Q2 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $365.4 million (2023), against an average of $343.2 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) plunged 99.24% in 2021 and soared 26091.32% in 2022, its largest moves.
  • Vivos' Shares Outstanding (Weighted Average) stood at $325.9 million in 2021, then grew by 7.85% to $351.4 million in 2022, then grew by 4.95% to $368.8 million in 2023, then gained by 11.08% to $409.7 million in 2024, then gained by 10.51% to $452.7 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $452.7 million (Q4 2025), $452.0 million (Q3 2025), and $453.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.74 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 382.90 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 579.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 456.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 385.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 98.20 Mn
10 Vivos - - -3,105.00 452.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 452.72 Mn
Sep 30, 2025 452.04 Mn
Jun 30, 2025 453.51 Mn
Mar 31, 2025 448.23 Mn
Dec 31, 2024 409.67 Mn
Sep 30, 2024 418.63 Mn
Jun 30, 2024 24.53 Mn
Mar 31, 2024 389.41 Mn
Dec 31, 2023 368.81 Mn
Sep 30, 2023 370.54 Mn
Jun 30, 2023 368.17 Mn
Mar 31, 2023 362.54 Mn
Dec 31, 2022 351.43 Mn
Sep 30, 2022 343.91 Mn
Jun 30, 2022 343.76 Mn
Mar 31, 2022 343.61 Mn
Dec 31, 2021 325.85 Mn
Sep 30, 2021 335.51 Mn
Jun 30, 2021 1.31 Mn
Mar 31, 2021 300.54 Mn